Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-13T07:02:31.797Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroimmune mechanisms in cancer: implications for psychiatry

Published online by Cambridge University Press:  13 June 2014

Malcolm Garland  and
Noel Walsh
Malcolm Garland
Affiliation:
Department of Psychiatry, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland
Noel Walsh
Affiliation:
Department of Psychiatry, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Irish Journal of Psychological Medicine , Volume 16 , Issue 3 , September 1999 , pp. 82 - 83
Copyright
Copyright © Cambridge University Press 1999

References

1.Derogatis, CR, Morrow, GR, Fetting, J, Penman, Det al.The prevalence of psychiatric disorders among cancer patients JAMA 1983; 249: 751–7.Google Scholar
2.Funch, DP, Marshall, J. The role of stress, social support and age on survival from breast cancer. Psychosom Res 1983: 27: 77–83.Google Scholar
3.Fawzy, FI, Fawzy, NW, Arudt, LA, Pasnau, RO. Critical review of psychosocial interventions in cancer care. Arch Gen Psychiat 1995; 52: 100–13.Google Scholar
4.Besedovsky, HO, Del, RevA. Immune-neuro-endocrine interactions: facts and hypotheses. Endocrine Rev 1996; 17: 64–102.CrossRefGoogle Scholar
5.Buckingham, JC. Stress and the neuroendocrine-immune axis: the pivotal role of lipocortin-1. Br J Pharmacol 1996; 118: 1–19.Google Scholar
6.Auphan, N, DiDonato, JA, Rosette, C, Helmberg, A, Karin, M. Immunosuppression bv glucocorticoids: inhibition of NF-KB activity, through induction of 1KB synthesis. Science 1995; 270: 286–9.Google Scholar
7.Riley, V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 1981; 212: 110–19.Google Scholar
8.Li, T, Harada, M, Abe, K, Nomoto, K. Repeated restraint stress impairs the anti-tumour T-cell response through its suppressive effect on Th1-type CD4+ cells. Anticancer Res 1997; 17: 4259–68.Google Scholar
9.Felten, DL, Felten, SY, Carison, SL, Olschowka, JA, Livnat, S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 1985; 135: 755S–65S.Google Scholar
10.Shakhar, C, Ben-Eliyahu, SB. In vivo β-adrenergic stimulation suppresses NKA and compromises resistance to tumour metastasis in rats. J Immunol 1998; 160: 3251–8.Google Scholar
11.Irwin, M, Brown, M, Patterson, T, Haugher, Ret al.Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEBJ. 1991; 5: 3100–7.Google Scholar
12.Ader, R, Cohen, N, Felten, D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995; 345: 99–103.Google Scholar
13.Jessop, DS. β-endorphin in the immune system – mediator of pain and stress? Lancet 1998; 351: 1828–9.Google Scholar
14.Shavit, Y, Terman, GW, Martin, FC, Lewis, JW, Liebeskind, JC, Gale, RP. Stress, opioid peptides, the immune system and cancer. J Immunol 1985; 135(2): 834S–7S.Google Scholar
15.Lewis, JW, Tordoff, MG, Sherman, JE, Liebeskind, JC. Adrenal medullary, enkephalin-like peptides may mediate opioid stress analgesia. Science 1982; 217: 557.Google Scholar
16.Irwin, M. Psychoneuroimmunology of depression. In: Psychopharmacology: The Fourth Generation of Progress. Eds: Bloom, FE, Kupfer, DJ. Raven Press Ltd. New York: 1995.Google Scholar
17.Kiecolt-Glaser, JK, Marucha, PT, Malarkey, WB, Mercado, AM; Glaser, R. Slowing of wound healing by psychological stress. Lancet 1995; 346: 1194–5.Google Scholar
18.Brittenden, J, Heys, SD, Ross, J, Eremin, O. Natural killer cells and cancer. Cancer 1996; 77: 1226–43.Google Scholar
19.Hanna, N. Inhibition of experimental tumour metastasis by selective activation of NK cells. Cancer Res 1982; 42; 1337–42.Google Scholar
20.Baral, F, Nagy, E, Berzi, I. Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol. Cancer 1995; 75(2): 591–9.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
21.Spector, NH. Neuroimmunomodulation: a brief review. Regul Toxicol Pharmacol 1996; 24: S32–8.Google Scholar
22.Evans, DL, Folds, JD, Petitto, JM, Golden, RNet al.Circulating natural killer cell phenotypes in men and women with major depression. Arch Gen Psychiat 1992; 49: 388–95.Google Scholar
23.Joffe, RT, Rubinow, DR, Denicoff, KD. Depression and carcinoma of the pancreas. Gen Hosp Psychiat 1986; 8: 241–45.CrossRefGoogle ScholarPubMed
24.Haas, HS, Schaunstein, K. Neuroimmunomodulation via limbic structures – the neuroanatomy of Psychoimmunology. Prog Neurobioi 1997; 51:195–222.Google Scholar
25.Spiegel, D, Bloom, JR, Kraemer, HC, Gottheil, E. Effect of psychosocial treatment on survival of patients metastatic breast cancer. Lancet 1989; ii: 888–91.Google Scholar